Fundraising Fox
Evelo Biosciences
Cambridge, US · Founded 2014 · Delaware corporation · 16 employees on LinkedIn · 7 known investors
Find your way into Evelo Biosciences
Sign up to see every warm intro you have to Evelo Biosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Evelo Biosciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
JG
Jennifer GlennonVice President, Finance and Operations2015–2018Jennifer Glennon has held executive leadership roles in strategy, finance, and operations across public and venture-backed biotech companies, with experience managing large R&D budgets, clinical trial portfolios, and preparing multiple organizations for IPO. She has also worked with a biotech-focused asset management firm and holds expertise in financial management, regulatory compliance, and international operations.
B(
Balkrishan (Simba) Gill, Ph.D.Executive
WD
William DeVaulVice President, Intellectual Property2015–2019William DeVaul is an attorney and executive who has held leadership roles at three public biopharmaceutical companies and helped found private companies in quantum software and fine chemicals. He has experience structuring corporate financings, mergers, intellectual property strategy, and corporate governance.
MB
Mark Bodmer, Ph.D.Executive
Board
NB
Noubar B. Afeyan, Ph.D.Board directorGeneral Partner at Flagship Pioneering
DR
David R. EpsteinBoard director
LA
Lord Ara DarziBoard director
DP
David P. PerryBoard director
TM
Theodose Melas-KyriaziBoard director
Investors · 7
GV (Google Ventures)listed by GV (Google Ventures)Mountain View · $250K – $50M
How we know: GV (Google Ventures)'s portfolio page · prnewswire.com · Not right? Tell us
SV Health Investorslisted by SV Health InvestorsLondon · $1M – $20M
How we know: SV Health Investors's portfolio page · Not right? Tell us
AlexandriareportedPasadena
How we know: prnewswire.com · Not right? Tell us
Flagship PioneeringreportedCambridge · $500K – $10M
How we know: funding news · prnewswire.com · Not right? Tell us
Kaiser Permanente VenturesreportedSan Francisco · $2M – $5M
How we know: funding news · Not right? Tell us
Also in the syndicate · 1
Celgene
Reported raises · per SEC filings
Form D private placements$131.5M disclosed across 2 rounds · 2017–2018
▶$81.5MraisedMar 2018 · 15 investors · BiotechnologyRule 506(b)
▶$81.5MraisedMar 2018 · 15 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Noubar B. Afeyan, Ph.D.Director
- Jennifer GlennonExecutive Officer
- Balkrishan (Simba) Gill, Ph.D.Executive Officer, Director
- David R. EpsteinDirector
- Lord Ara DarziDirector
- Duncan McHaleExecutive Officer
- David P. PerryDirector
- William DeVaulExecutive Officer
- Mark Bodmer, Ph.D.Executive Officer
- Theodose Melas-KyriaziDirector
- Offering amount
- $81.5M
- Amount sold
- $81.5M
- First sale
- Feb 2018
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$50MraisedFeb 2018 · 11 investors · BiotechnologyRule 506(b)
▶$50MraisedFeb 2018 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Balkrishan (Simba) Gill, Ph.D.Executive Officer, Director
- David P. PerryDirector
- David A. Berry, M.D., Ph.D.Director
- Mark Bodmer, Ph.D.Executive Officer
- William DeVaulExecutive Officer
- Jennifer GlennonExecutive Officer
- Theodose Melas-KyriaziDirector
- Lord Ara DarziDirector
- David R. EpsteinDirector
- Duncan McHaleExecutive Officer
- Noubar B. Afeyan, Ph.D.Director
- Offering amount
- $50M
- Amount sold
- $50M
- First sale
- Jan 2017
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
3 people who came through Evelo Biosciences went on to found or lead other companies.
Frequently asked questions
- Who are Evelo Biosciences's investors?
- Evelo Biosciences's investors include GV (Google Ventures), SV Health Investors, Alexandria, Flagship Pioneering, Kaiser Permanente Ventures, Mayo Clinic Ventures.
- How much funding has Evelo Biosciences raised?
- Evelo Biosciences has disclosed $131.5M raised across 2 rounds.
- Where is Evelo Biosciences headquartered?
- Evelo Biosciences is headquartered in Cambridge, US.